Established in 2003, Infinium Pharmachem Limited is a leading manufacturer and supplier of Iodine Derivatives, APIs, and Iodination reaction-based bulk drugs.
The company specializes in providing comprehensive R&D services, as well as commercial scale manufacturing and packaging solutions for various industries, including Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals, and others.
Infinium Pharmachem operates a state-of-the-art manufacturing plant located in Gujarat, India, covering a vast plot area of 4100 Sq. Mtr. The facility holds prestigious FDA certification and adheres to Good Manufacturing Practices (GMP), enabling the production of complex Iodine Derivatives.
With a global outlook, the company caters to a diverse clientele spread across 15+ countries. Infinium Pharmachem takes pride in offering an extensive range of more than 200+ Iodine Derivatives and 7+ APIs, showcasing its commitment to meeting the evolving needs of its customers worldwide.
Backed by cutting-edge technology, FDA compliance, and a wide product portfolio, Infinium Pharmachem Limited continues to excel as a leading player in the pharmaceutical and chemical industries, delivering high-quality products and services to a global market.
Infinium Pharmachem Limited Stock Quote #
- Open: ₹301.00
- High – Low: ₹317.95 – ₹290.20
- Previous Close: ₹294.50
- Total Traded Value: 65,000
- Updated On: Jul 24, 2023 4:00 PM
Infinium Pharmachem IPO Details #
| IPO Date | Mar 31, 2023 to Apr 5, 2023 |
| Listing Date | Apr 17, 2023 |
| Face Value | ₹10 per share |
| Price | ₹135 per share |
| Lot Size | 1000 Shares |
| Total Issue Size | 1,875,000 shares (aggregating up to ₹25.26 Cr) |
| Fresh Issue | 1,875,000 shares (aggregating up to ₹25.26 Cr) |
| Employee Discount | Rs 13.5 per share |
| Issue Type | Fixed Price Issue IPO |
| Listing At | NSE SME |
| Market Maker portion | 94,000 shares Swastika Investmart |
Infinium Pharmachem IPO Reservation #
| Anchor Investor Shares Offered | – |
| Market Maker Shares Offered | 94,000 (4.77%) |
| Other Shares Offered | 937,500 (47.61%) |
| Retail Shares Offered | 937,500 (47.61%) |
| Total Shares Offered | 1,969,000 (100%) |
Infinium Pharmachem IPO Timetable (Tentative) #
Infinium Pharmachem IPO opens on Mar 31, 2023, and closes on Apr 5, 2023.
| Event | Tentative Date |
|---|---|
| Opening Date | Friday, 31 March 2023 |
| Closing Date | Wednesday, 5 April 2023 |
| Basis of Allotment | Tuesday, 11 April 2023 |
| Initiation of Refunds | Wednesday, 12 April 2023 |
| Credit of Shares to Demat | Thursday, 13 April 2023 |
| Listing Date | Monday, 17 April 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on Apr 5, 2023 |
Infinium Pharmachem IPO Lot Size #
The Infinium Pharmachem IPO lot size is 1000 shares.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1000 | ₹135,000 |
| Retail (Max) | 1 | 1000 | ₹135,000 |
| HNI (Min) | 2 | 2,000 | ₹270,000 |
| Lot Size Calculator | |||
Infinium Pharmachem IPO Promoter Holding #
Mr. Sanjaykumar Viththalbhai Patel, Mr. Pravin Bhadabhai Madhani, and Mr. Mitesh Lavjibhai Chikhaliya are the company promoters.
| Pre Issue Share Holding | 100% |
| Post Issue Share Holding | 73.05% |
Company Financials #
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Total Borrowing |
|---|---|---|---|---|---|
| 31-Mar-20 | 2,244.60 | 3,941.64 | 93.40 | 424.74 | 566.17 |
| 31-Mar-21 | 3,418.27 | 7,115.37 | 272.48 | 702.32 | 579.47 |
| 31-Mar-22 | 5,899.95 | 10,005.25 | 610.64 | 1,310.22 | 1,385.01 |
| 30-Sep-22 | 7,075.71 | 7,985.39 | 551.01 | 1,855.77 | 1,614.71 |
| Amount in ₹ Lakhs | |||||
Key Performance Indicator #
| KPI | Values |
|---|---|
| P/E (x) | 7.83 |
| Market Cap (₹ Cr.) | 93.93 |
Objects of the Issue #
The proceeds from the fresh issue will be utilized for the following objects:
1. Marketing and branding expenses (including registration in reach – Europe, and other marketing expenses).
2. Repayment of some of the existing loans and expansion of units.
3. To meet incremental working capital requirements.
4. To meet public issue expenses.
Infinium Pharmachem IPO Subscription Status (Bidding Detail) #
The Infinium Pharmachem IPO is subscribed 1.84 times on Apr 5, 2023 7:30:00 PM. The public issue subscribed 1.86 times in the retail category, times in the QIB category, and 1.80 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| Other | 1.80 |
| Retail | 1.86 |
| Total | 1.84 |
Total Application : 1,742 (1.86 times)
Infinium Pharmachem IPO Prospectus #
- › Infinium Pharmachem IPO DRHP
- › Infinium Pharmachem IPO RHP
Infinium Pharmachem IPO Listing Details #
| Listing Date | Apr 17, 2023 |
| BSE Script Code | |
| NSE Symbol | INFINIUM |
| ISIN | INE0MRE01011 |
| Final Issue Price | ₹135 per share |
Listing Day Trading Information #
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| NSE SME |
|---|
| ₹135.00 |
| ₹141.50 |
| ₹141.50 |
| ₹148.55 |
| ₹147.80 |
Check IPO Performance…
Company Contact Information #
38 G.I.D.C Sojitra,
Taluka – Sojitra,
Dist. – Anand – 387240
Phone: +91-2692-238849
Email: info@infiniumpharmachem.com
Website: https://infiniumpharmachem.com/
Infinium Pharmachem IPO Registrar #
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html
Infinium Pharmachem IPO Lead Manager(s) #
Frequently Asked Questions #
When does the Infinium Pharmachem IPO open and close? #
The Infinium Pharmachem IPO opens on March 31, 2023, and closes on April 5, 2023.
What is the IPO price and face value of Infinium Pharmachem IPO? #
The IPO price of Infinium Pharmachem is ₹135 per equity share, and the face value is ₹10 per share.
What is the IPO size and lot size of Infinium Pharmachem IPO? #
The Infinium Pharmachem IPO size is ₹25.26 Crores, and the lot size is 1000 shares.
Where will Infinium Pharmachem IPO be listed? #
Infinium Pharmachem IPO will be listed on NSE SME on April 17, 2023.
What is the subscription status of Infinium Pharmachem IPO? #
As of the latest update, the IPO has been subscribed 1.84 times, with Qualified Institutional Buyers (QIB) subscribing 1.80 times, Non-Institutional Investors (NII) subscribing 1.86 times, and Retail Individual Investors (RII) subscribing 1.84 times.
What is the business of Infinium Pharmachem Limited? #
Infinium Pharmachem Limited manufactures and supplies Iodine Derivatives, APIs, and Iodination reaction-based bulk drugs. The company also offers R&D services and commercial scale manufacturing and packaging for Pharmaceutical, Agrochemical, Nutraceutical, Specialty Chemicals, and other chemical industries.
Where is the manufacturing plant of Infinium Pharmachem located? #
Infinium Pharmachem’s manufacturing plant is located in Gujarat, India, spanning across a 4100 Sq. Mtr. plot area.
What is the post-issue paid-up capital of Infinium Pharmachem Limited? #
Post-IPO, Infinium Pharmachem’s current paid-up equity capital of Rs. 4.59 cr. will stand enhanced to Rs. 6.30 cr.
What are the financial details of Infinium Pharmachem Limited? #
For the last three fiscal years, Infinium Pharmachem Limited has posted a turnover/net profit of Rs. 8.97 cr./ Rs. 0.04 cr. (FY20), Rs. 9.00 cr./ Rs. 0.19 cr. (FY21), and Rs. 19.22 cr./ Rs. 0.44 cr. (FY22). For H1 FY23 ended on September 30, 2022, it earned a net profit of Rs. 0.86 cr. on a turnover of Rs. 13.05 cr.
What are the objects of the Infinium Pharmachem IPO? #
The proceeds from the fresh issue will be utilized for marketing and branding expenses, repayment of some existing loans and expansion of units, meeting incremental working capital requirements, and meeting public issue expenses.
Please note that the information provided here is based on the available data and may be subject to change. For the most up-to-date and accurate information, it is recommended to visit the official sources and financial portals directly.
